Risk and Medical Decision Making: Studies in Risk and Uncertainty, cartea 14
Autor Louis Eeckhoudten Limba Engleză Paperback – noi 2012
In Risk and Medical Decision Making, part 1 is developed inside the expected utility (E-U) model and analyses how comorbidity risks affect the well-known "test-treatment" thresholds. Part 2 is devoted to a specific non E-U model with the same purpose: how would one define a threshold in this context and how would one value a diagnostic test? In each of these two parts both diagnostic and therapeutic risks are considered.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 633.02 lei 6-8 săpt. | |
Springer Us – noi 2012 | 633.02 lei 6-8 săpt. | |
Hardback (1) | 638.57 lei 6-8 săpt. | |
Springer Us – 30 apr 2002 | 638.57 lei 6-8 săpt. |
Din seria Studies in Risk and Uncertainty
- Preț: 104.32 lei
- Preț: 393.74 lei
- 18% Preț: 953.03 lei
- 15% Preț: 647.08 lei
- 18% Preț: 1491.25 lei
- 15% Preț: 641.38 lei
- 15% Preț: 640.24 lei
- 15% Preț: 645.47 lei
- 18% Preț: 1224.06 lei
- 15% Preț: 638.89 lei
- 18% Preț: 950.66 lei
- 18% Preț: 941.68 lei
- 18% Preț: 946.24 lei
- 18% Preț: 954.93 lei
- 15% Preț: 640.24 lei
Preț: 633.02 lei
Preț vechi: 744.73 lei
-15% Nou
Puncte Express: 950
Preț estimativ în valută:
121.15€ • 125.52$ • 101.10£
121.15€ • 125.52$ • 101.10£
Carte tipărită la comandă
Livrare economică 21 martie-04 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461353409
ISBN-10: 1461353408
Pagini: 144
Ilustrații: V, 135 p.
Dimensiuni: 155 x 235 x 8 mm
Greutate: 0.21 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Seria Studies in Risk and Uncertainty
Locul publicării:New York, NY, United States
ISBN-10: 1461353408
Pagini: 144
Ilustrații: V, 135 p.
Dimensiuni: 155 x 235 x 8 mm
Greutate: 0.21 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Seria Studies in Risk and Uncertainty
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1: Introduction.- 1: Developments inside the E-U model.- 2: The case of diagnostic risks in a single risk environment.- 3: The introduction of “comorbidity risks” and the treatment threshold. The notion of prudence.- 4: Treatment decisions under therapeutic risks.- 5: The value of diagnostic tests (under risk neutrality).- 6: Risk aversion and diagnostic tests.- 7: Comorbidity risks and the value of a test: a short overview.- 2: M.D.M and new models of choice under risk.- 8: Treatment thresholds and the dual theory of choice under risk.- 9: Diagnostic tests and the dual theory.- Conclusions.- References.